Top Story

Skin self-examination training benefits varied depending on relationship of patients, partners

October 6, 2015

Patients with melanoma and skin-check partners who spent the least time together and had the least happiness in their relationship may have received greater benefits from a skin self-examination intervention than those with higher relationship quality, according to recently published study results.

Researchers conducted a randomized clinical trial between Jun 6, 2011, and April 14, 2014, which included 494 patients with stage 0 to IIB melanoma (mean age, 55 years; 51.2% female) and their skin-check partners (mean age, 55 years; 56.7% female). Follow-up assessments were performed at 1 year, and analysis was conducted.

Michael Silverberg In the Journals

Individuals with HIV living long enough to develop cancer

October 6, 2015
The cumulative incidence of certain cancers has increased among individuals with HIV because they are living longer, according to data from the North American AIDS…
Meeting News Coverage

ASCO, AAHPM issue guidance statement on hospice, palliative care in oncology practice

October 6, 2015
ASCO and the American Academy of Hospice and Palliative Medicine have issued a guidance statement outlining strategies for high-quality palliative care delivered by…

Exercise during cancer treatment improves quality of life

October 6, 2015
Guidelines from the American College of Sports Medicine strongly recommend individuals with cancer, as well as cancer survivors, incorporate exercise into their daily…
Rebecca Richards-Kortum In the Journals

Imaging systems may diagnose breast cancer without histologic assessment

October 6, 2015
Proflavine staining and confocal fluorescence microscopy in combination with image analysis strategies to segment morphological features may diagnose breast cancer in…
More News Headlines »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Hematology Oncology Case Consults

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »